Systematic review assesses infectiousness predictors of SARS-CoV-2 using cycle threshold values, guiding clinical decisions.
We sought to assess predictive factors for SARS-CoV-2 infectiousness using a meta-analytic approach.We searched LitCovid, medRxiv, Google Scholar, and the WHO COVID-19 database until June 30 2025, including studies which cultured SARS-CoV-2, relating them to clinico-epidemiologic and laboratory variables and RT-PCR cycle threshold (Ct) values.Using linear mixed effects regression models, we tested for independent associations with Ct values with 95%CIs and adjusted p-values in a multivariable model.We used a modified QUADAS criteria to assess risk-of-bias.We included 50 studies, with 39 in quantitative synthesis.The percentage of culture-positive specimens decreased with increasing Ct values (subgroup test difference Q=96.71;p<0.001) and time since the first PCR test (Q=26.95;p=0.0026).Presence of symptoms (Q=20.1;p<0.01),gene platform used (Q=14.89;p=0.002),being a cancer patient (Q=24.9;p<0.0001)and vaccination status (Q=8.80;p=0.012)were associated with increased culture-positivity, whereas a rising Ct (adjusted Ct change -6.58[95%CI] -5.30, -7.86;p<0.001) was strongly associated with culture-negativity.Analyzing 186 immunocompetent patients with 1393 Ct values, 2 consecutive Cts 30 or a rising Ct value on serial testing demonstrated a sensitivity of 87.5% and specificity of 96.3% using culture positivity as the outcome.Serial Ct monitoring, integrated with clinico-epidemiologic data is a valuable tool for assessing infectiousness, providing objective criteria for discontinuing isolation and guiding clinical decisions.
No takes yet. Share an insight, caveat, or question.
Roşca et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: